https://edgen.pre.edgen.tech/zh/news/post/veracyte-to-present-data-from-2-phase-iii-cancer-trials-at-asco-20262026-05-21T22:25:19.544Zdaily1Edgen Stockzh2026-05-21T22:25:19.544+00:00Veracyte 将在 2026 年 ASCO 年会上展示两项 III 期癌症试验数据https://static.edgen.tech/news/images/veracyte-to-present-data-from-2-phase-iii-cancer-trials-at-asco-2026-20260521.pngVeracyte 将在 2026 年 ASCO 年会上展示两项 III 期癌症试验数据 https://edgen.pre.edgen.tech/zh/news/post/aktis-aky-2519-shows-404-suvmax-uptake-in-first-human-cancer-trial2026-05-21T22:00:37.353Zdaily1Edgen Stockzh2026-05-21T22:00:37.353+00:00Aktis 的 AKY-2519 在首次人体癌症试验中显示 40.4 SUVmax 摄取https://static.edgen.tech/news/images/aktis-aky-2519-shows-404-suvmax-uptake-in-first-human-cancer-trial-20260521.pngAktis 的 AKY-2519 在首次人体癌症试验中显示 40.4 SUVmax 摄取 https://edgen.pre.edgen.tech/zh/news/post/zoom-raises-fy2027-forecast-to-over-5-billion-on-ai-demand2026-05-21T21:59:44.348Zdaily1Edgen Stockzh2026-05-21T21:59:44.348+00:00Zoom 受 AI 需求推动将 2027 财年指引上调至逾 50 亿美元https://static.edgen.tech/news/images/zoom-raises-fy2027-forecast-to-over-5-billion-on-ai-demand-20260521.pngZoom 受 AI 需求推动将 2027 财年指引上调至逾 50 亿美元 https://edgen.pre.edgen.tech/zh/news/post/nuvalent-to-show-40-response-rate-for-zidesamtinib-pivotal-lung-cancer-data-at-asco2026-05-21T21:59:20.835Zdaily1Edgen Stockzh2026-05-21T21:59:20.835+00:00Nuvalent将在ASCO展示zidesamtinib 40%的缓解率及肺癌关键数据https://static.edgen.tech/news/images/nuvalent-to-show-40-response-rate-for-zidesamtinib-pivotal-lung-cancer-data-at-asco-20260521.pngNuvalent将在ASCO展示zidesamtinib 40%的缓解率及肺癌关键数据 https://edgen.pre.edgen.tech/zh/news/post/amex-exploration-secures-c59-million-to-fund-perron-gold-project2026-05-21T21:56:33.324Zdaily1Edgen Stockzh2026-05-21T21:56:33.324+00:00Amex Exploration 获得 0.59 亿加元资金用于 Perron 黄金项目https://static.edgen.tech/news/images/amex-exploration-secures-c59-million-to-fund-perron-gold-project-20260521.pngAmex Exploration 获得 0.59 亿加元资金用于 Perron 黄金项目 https://edgen.pre.edgen.tech/zh/news/post/turkish-stocks-plunge-6-after-court-ousts-opposition-leader2026-05-21T21:38:28.152Zdaily1Edgen Stockzh2026-05-21T21:38:28.152+00:00法院罢免反对党领袖后 土耳其股市暴跌 6%https://static.edgen.tech/news/images/turkish-stocks-plunge-6-after-court-ousts-opposition-leader-20260521.png法院罢免反对党领袖后 土耳其股市暴跌 6% https://edgen.pre.edgen.tech/zh/news/post/black-diamond-rises-on-152-month-cancer-trial-result2026-05-21T21:33:26.355Zdaily1Edgen Stockzh2026-05-21T21:33:26.355+00:00Black Diamond 股价因 15.2 个月癌症试验结果大涨https://static.edgen.tech/news/images/black-diamond-rises-on-152-month-cancer-trial-result-20260521.pngBlack Diamond 股价因 15.2 个月癌症试验结果大涨 https://edgen.pre.edgen.tech/zh/news/post/why-a-9010-portfolio-may-be-better-than-6040-for-some-investors2026-05-21T21:32:58.150Zdaily1Edgen Stockzh2026-05-21T21:32:58.150+00:00为什么 90/10 投资组合对某些投资者来说可能优于 60/40https://static.edgen.tech/news/images/why-a-9010-portfolio-may-be-better-than-6040-for-some-investors-20260521.png为什么 90/10 投资组合对某些投资者来说可能优于 60/40 https://edgen.pre.edgen.tech/zh/news/post/merck-lung-cancer-combo-with-kelun-hits-70-response-rate2026-05-21T21:32:56.140Zdaily1Edgen Stockzh2026-05-21T21:32:56.140+00:00默沙东与科伦博泰肺癌联合疗法客观缓解率达 70%https://static.edgen.tech/news/images/merck-lung-cancer-combo-with-kelun-hits-70-response-rate-20260521.png默沙东与科伦博泰肺癌联合疗法客观缓解率达 70% https://edgen.pre.edgen.tech/zh/news/post/imax-surges-15-on-reports-of-a-potential-sale2026-05-21T21:30:24.743Zdaily1Edgen Stockzh2026-05-21T21:30:24.743+00:00IMAX 传出考虑出售消息，股价飙升 15%https://static.edgen.tech/news/images/imax-surges-15-on-reports-of-a-potential-sale-20260521.pngIMAX 传出考虑出售消息，股价飙升 15% https://edgen.pre.edgen.tech/zh/news/post/bicara-cancer-drug-doubles-survival-rate-to-31-in-head-and-neck-trial2026-05-21T21:29:39.126Zdaily1Edgen Stockzh2026-05-21T21:29:39.126+00:00Bicara抗癌药物在头颈癌试验中将生存率翻倍至31%https://static.edgen.tech/news/images/bicara-cancer-drug-doubles-survival-rate-to-31-in-head-and-neck-trial-20260521.pngBicara抗癌药物在头颈癌试验中将生存率翻倍至31% https://edgen.pre.edgen.tech/zh/news/post/syndax-to-present-new-revuforj-data-from-4-leukemia-trials-at-asco2026-05-21T21:28:58.729Zdaily1Edgen Stockzh2026-05-21T21:28:58.729+00:00Syndax 将在 ASCO 展示 Revuforj 治疗白血病的 4 项临床试验新数据https://static.edgen.tech/news/images/syndax-to-present-new-revuforj-data-from-4-leukemia-trials-at-asco-20260521.pngSyndax 将在 ASCO 展示 Revuforj 治疗白血病的 4 项临床试验新数据 https://edgen.pre.edgen.tech/zh/news/post/remix-drug-shows-43-response-rate-in-rare-cancer-trial2026-05-21T21:26:22.521Zdaily1Edgen Stockzh2026-05-21T21:26:22.521+00:00Remix 药物在罕见癌症试验中显示出 43% 的缓解率https://static.edgen.tech/news/images/remix-drug-shows-43-response-rate-in-rare-cancer-trial-20260521.pngRemix 药物在罕见癌症试验中显示出 43% 的缓解率 https://edgen.pre.edgen.tech/zh/news/post/akaris-cancer-drug-shows-high-synergy-with-kras-inhibitors2026-05-21T21:26:17.125Zdaily1Edgen Stockzh2026-05-21T21:26:17.125+00:00Akari 癌症药物与 KRAS 抑制剂显示高度协同作用https://static.edgen.tech/news/images/akaris-cancer-drug-shows-high-synergy-with-kras-inhibitors-20260521.pngAkari 癌症药物与 KRAS 抑制剂显示高度协同作用 https://edgen.pre.edgen.tech/zh/news/post/dow-surges-351-points-to-new-record-as-investors-rotate-to-tech2026-05-21T21:25:29.346Zdaily1Edgen Stockzh2026-05-21T21:25:29.346+00:00道指飙升 351 点创下新纪录，投资者向科技股调仓https://static.edgen.tech/news/images/dow-surges-351-points-to-new-record-as-investors-rotate-to-tech-20260521.png道指飙升 351 点创下新纪录，投资者向科技股调仓 https://edgen.pre.edgen.tech/zh/news/post/seer-rejects-radoff-jecs-240-per-share-takeover-bid2026-05-21T20:56:36.322Zdaily1Edgen Stockzh2026-05-21T20:56:36.322+00:00Seer 拒绝 Radoff-JEC 每股 2.40 美元的收购报价https://static.edgen.tech/news/images/seer-rejects-radoff-jecs-240-per-share-takeover-bid-20260521.pngSeer 拒绝 Radoff-JEC 每股 2.40 美元的收购报价 https://edgen.pre.edgen.tech/zh/news/post/lucid-group-faces-fraud-inquiry-after-revenue-miss-sinks-stock-72026-05-21T20:55:35.528Zdaily1Edgen Stockzh2026-05-21T20:55:35.528+00:00Lucid Group 因营收不及预期导致股价大跌 7%，现面临欺诈调查https://static.edgen.tech/news/images/lucid-group-faces-fraud-inquiry-after-revenue-miss-sinks-stock-7-20260521.pngLucid Group 因营收不及预期导致股价大跌 7%，现面临欺诈调查 https://edgen.pre.edgen.tech/zh/news/post/baycom-stock-drops-11-as-law-firm-probes-executive-exodus2026-05-21T20:55:25.937Zdaily1Edgen Stockzh2026-05-21T20:55:25.937+00:00BayCom 股价因律师事务所调查高管离职而下跌 11%https://static.edgen.tech/news/images/baycom-stock-drops-11-as-law-firm-probes-executive-exodus-20260521.pngBayCom 股价因律师事务所调查高管离职而下跌 11% https://edgen.pre.edgen.tech/zh/news/post/carmax-faces-investor-investigation-after-stock-plunges-152026-05-21T20:55:23.154Zdaily1Edgen Stockzh2026-05-21T20:55:23.154+00:00CarMax 股价暴跌 15% 后面临投资者调查https://static.edgen.tech/news/images/carmax-faces-investor-investigation-after-stock-plunges-15-20260521.pngCarMax 股价暴跌 15% 后面临投资者调查 https://edgen.pre.edgen.tech/zh/news/post/abbvies-boey-gets-positive-eu-opinion-for-30-markets2026-05-21T20:31:25.736Zdaily1Edgen Stockzh2026-05-21T20:31:25.736+00:00艾伯维博毅 (Boey) 获欧洲 30 个市场积极监管意见https://static.edgen.tech/news/images/abbvies-boey-gets-positive-eu-opinion-for-30-markets-20260521.png艾伯维博毅 (Boey) 获欧洲 30 个市场积极监管意见